No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
144 |
4. Check minimum number of eventsNone |
144 |
5. Include endpointsNone |
144 |
6. Filter based on genotype QC (FinnGen only) |
144 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Atrioventricular septal defect
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of heart and great arteries
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2000 | 1168 | 826 |
| Only index persons | 1460 | 841 | 619 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 4.19 | 4.72 | 3.16 |
| Only index persons | 8.98 | 10.27 | 7.24 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 144 | 90 | 54 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | 28.38 | 24.60 | 34.67 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 132
- Matched controls
- 1321
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q21.20
ICD-10 Finland
Atrial septal defect of primum type
+∞
63.8
56
*
Q21.21
ICD-10 Finland
Atrioventricular duct
+∞
58.8
52
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
33.3
47.6
64
36
Q21.10
ICD-10 Finland
Persistent ostium secundum
64.7
45.9
52
13
201
Kela drug reimbursment
Chronic cardiac insufficiency
59.7
40.9
47
12
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
13.0
32.8
66
94
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
11.0
31.8
73
133
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
26.8
31.5
44
24
XF404
NOMESCO Finland
Ambulatory ECG
15.4
26.7
46
44
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
107.0
24.7
26
*
C01AA05
ATC
digoxin; systemic
30.6
23.5
31
13
Q21.19
ICD-10 Finland
Atrial septal defect NOS
64.0
23.0
26
5
Q21.29
ICD-10 Finland
Atrioventricular septal defect UNS
+∞
22.5
21
*
XF620
NOMESCO Finland
Examination of circulation with color method
137.9
22.3
23
*
B01AA03
ATC
warfarin; systemic
10.5
22.3
47
66
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
8.6
20.7
50
87
Q21.2
ICD-10 Finland
Atrioventricular septal defect
+∞
19.2
18
*
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
116.8
19.1
20
*
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
30.4
19.1
25
10
C03CA01
ATC
furosemide; systemic
6.7
17.7
52
117
XF400
NOMESCO Finland
ECG with 12 standard connections
6.3
17.2
53
127
WX872
NOMESCO Finland
Intensive care
16.6
16.9
27
20
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.9
16.4
80
317
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
68.8
16.2
18
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
6.9
16.0
44
89
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
6.2
15.5
47
108
31
HP
Congenital heart failure surgery
64.4
15.2
17
*
C03DA01
ATC
spironolactone; oral
9.8
14.9
31
40
7456C
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Endocardial cushion defects[ASD CANALIS ATRIOVENTRICULARIS COMMUNIS]
+∞
14.9
14
*
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
48.3
14.5
17
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
7.3
14.4
37
67
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
27.4
14.2
19
8
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
7.5
13.4
33
56
Q90.0
ICD-10 Finland
Trisomy 21, meiotic nondisjunction
142.9
12.7
13
*
XF402
NOMESCO Finland
ECG with work load test
7.3
12.5
31
53
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
+∞
11.6
11
*
Q90.9
ICD-10 Finland
Down syndrome, unspecified
130.9
11.6
12
*
TFP20
NOMESCO Finland
Cardiodefibrillation
11.7
11.5
21
21
TPH04
NOMESCO Finland
Cathetrisation of vein
4.5
11.4
46
140
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
47.7
11.1
13
*
FFC00
NOMESCO Finland
Suture of ostium secundum type ASD
31.0
11.0
14
5
62
HP
Catheterization and pressure measurement of the right side of the heart
+∞
10.5
10
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
11.5
10.4
19
19
207
Kela drug reimbursment
Chronic arrhythmias
6.6
10.0
26
47
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
28.5
10.0
13
5
61
HP
Catheterization and pressure measurement of the left side of the heart
59.4
9.8
11
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
13.8
9.6
16
13
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
19.3
9.6
14
8
Q20.48
ICD-10 Finland
Single ventricle
107.3
9.5
10
*
7580A
ICD-9 Finland
Chromosomal anomalies, Down's syndrome
+∞
9.5
9
*
FFD20
NOMESCO Finland
Closure of atrio-ventricular septal defect using patch
+∞
9.5
9
*
74646
ICD-8 Finland
Congenital anomalies of heart, Defectus septi atriorum, ostium primum
+∞
9.5
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
9.3
58
248
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.3
9.0
24
45
C07AA07
ATC
sotalol; systemic
17.8
8.7
13
8
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
10.5
8.6
16
17
AF1
HP
Surgery of congenital heart defect
+∞
8.4
8
*
Q21.28
ICD-10 Finland
Atrioventricular septal defect
+∞
8.4
8
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
15.8
8.4
13
9
C07AB07
ATC
bisoprolol; oral
3.1
8.2
57
257
FM2CE
NOMESCO Finland
NA
8.7
8.2
17
22
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
8.7
8.2
17
22
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
23.8
8.2
11
5
ZX120
NOMESCO Finland
Intravenous
5.4
8.0
24
52
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.8
7.9
36
119
TPH07
NOMESCO Finland
Cathetrisation of artery
4.7
7.9
27
68
K78
ICPC
Atrial fibrillation/flutter
8.9
7.9
16
20
7456B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Endocardial cushion defects[DEFECTUS SEPTI ATRIORUM, OSTII PRIMII]
+∞
7.4
7
*
WX882
NOMESCO Finland
High dependency care
5.8
7.3
20
39
I47.2
ICD-10 Finland
Ventricular tachycardia
21.4
7.2
10
5
XF622
NOMESCO Finland
Measurement of minute volume of heart
31.9
7.2
9
*
WX892
NOMESCO Finland
Monitored bed care
5.2
7.2
22
49
XFE00
NOMESCO Finland
Epicardial ultrasonography
14.8
7.0
11
8
I50.9
ICD-10 Finland
Heart failure, unspecified
5.4
6.9
20
42
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
17.9
6.9
10
6
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
42.3
6.8
8
*
Q25.0
ICD-10 Finland
Patent ductus arteriosus
23.9
6.8
9
*
WX704
NOMESCO Finland
Intubation
4.9
6.6
21
49
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.4
6.6
35
128
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
6.6
43
184
XA800
NOMESCO Finland
Neuropsychological investigation
6.1
6.6
17
31
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
7.2
6.6
15
23
C01BD01
ATC
amiodarone; systemic
15.3
6.5
10
7
I50.1
ICD-10 Finland
Left ventricular failure
15.3
6.5
10
7
UDC00
NOMESCO Finland
Ear microscopy
5.0
6.5
20
45
Q21.30
ICD-10 Finland
Tetralogy of Fallot
73.2
6.5
7
*
74663
ICD-8 Finland
Congenital anomalies of heart, Stenosis valvulae pulmonalis
73.2
6.5
7
*
Q21.9
ICD-10 Finland
Congenital malformation of cardiac septum, unspecified
73.2
6.5
7
*
C09AA02
ATC
enalapril; systemic
4.0
6.4
25
72
AN1
HP
Coronary angiography
5.5
6.3
18
37
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
28.1
6.3
8
*
AP3
HP
Catheterization of the right and left side of the heart
+∞
6.3
6
*
74639
ICD-8 Finland
Congenital anomalies of heart, Defectus septi ventriculorum
+∞
6.3
6
*
I27.0
ICD-10 Finland
Primary pulmonary hypertension
+∞
6.3
6
*
74647
ICD-8 Finland
Congenital anomalies of heart, Ostium atrioventriculare commune
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3032080) INR in Blood by Coagulation assay
79
345
3.86
14.51
21.9
6.8
inr
1.7
1.1
2.02
18
113
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
14
11
13.99
14.46
4.4
4.5
%
74.6
95.2
1.33
14
11
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
31
70
5.37
13.62
5.7
10.0
%
88.4
92.3
0.46
31
70
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
45
6.20
12.79
22.9
21.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
50
182
3.68
11.66
5.8
3.4
ng/l
739.4
162.1
1.03
45
117
(3003396) Base excess in Arterial blood by calculation
34
96
4.33
11.30
17.2
14.3
mmol/l
0.7
1.3
0.37
28
80
(3036489) Thrombin time
28
70
4.72
10.81
4.2
6.9
s
21.9
22.6
0.33
22
63
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
33
6.09
9.72
13.9
20.5
u/ml
0.3
0.4
0.72
13
24
(3047181) Lactate [Moles/volume] in Blood
16
30
5.88
8.42
5.3
20.5
mmol/l
1.0
1.3
1.08
16
25
(3019060) Gas panel - Arterial blood
21
54
4.38
7.75
3.8
12.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
22
62
4.01
7.19
4.6
5.9
%
207.6
179.3
0.63
22
62
(3007853) Bacteria identified in Skin by Aerobe culture
34
135
2.99
6.55
3.0
1.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
37
159
2.79
6.15
5.2
2.4
umol/l
13.7
13.5
0.08
37
147
(3042936) Bacteria identified in Isolate by Culture
35
154
2.68
5.52
3.1
2.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
116
2.88
5.46
2.1
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
98
689
2.32
5.24
6.0
3.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
252
2.36
5.19
4.0
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
78
509
2.16
4.90
5.6
4.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
118
2.70
4.76
2.1
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34
161
2.46
4.57
2.1
1.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
45
255
2.11
3.91
5.1
5.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
7
8
9.12
3.81
2.0
3.3
nmol/l
0.7
0.7
—
7
8
(4306422)
10
25
4.22
3.76
1.2
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
28
134
2.35
3.64
3.8
5.7
%
2.1
1.6
0.71
28
127
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
26
4.06
3.58
2.5
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
53
333
1.94
3.40
4.6
3.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
27
133
2.27
3.28
29.9
12.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
53
341
1.88
3.13
5.5
3.5
ng/l
33.8
32.4
0.03
37
207
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
75
539
1.82
3.09
15.6
10.6
mmol/l
1.2
1.2
2.43
69
464
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
27
137
2.19
3.05
33.2
14.9
mmol/l
25.5
24.9
0.51
27
137
(3045788) Cell count panel - Pleural fluid
5
5
10.29
3.00
2.8
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
13
5.60
2.90
1.7
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
9
6.90
2.89
1.7
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
23
4.10
2.82
13.2
19.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
40
242
1.90
2.81
4.3
3.4
mg/l
1.4
1.4
0.01
35
192
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
5
6
8.57
2.77
1.8
2.8
%
191.2
106.0
—
5
6
(3023520) Reticulocytes [#/volume] in Blood
20
94
2.31
2.70
3.5
3.9
e9/l
82.1
66.9
2.07
14
69
(3022493) Free Hemoglobin [Mass/volume] in Plasma
5
7
7.35
2.57
2.0
17.3
mg/l
140.4
173.0
—
5
7
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
12
45
2.82
2.52
9.6
6.0
%
61.3
55.8
0.32
12
45
(3041354) Potassium [Moles/volume] in Venous blood
6
12
5.16
2.42
4.5
2.6
mmol/l
4.1
4.0
—
6
12
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
8
6.42
2.39
1.0
1.4
umol/l
9.8
9.8
—
5
8
(3001604) Monocytes [#/volume] in Blood
81
625
1.68
2.39
8.9
8.1
e9/l
0.7
0.6
1.81
73
542
(3019198) Lymphocytes [#/volume] in Blood
83
646
1.67
2.35
8.8
8.1
e9/l
1.7
2.0
3.34
77
574
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
53
2.60
2.35
1.9
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
25
405
0.54
2.12
2.3
1.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
80
628
1.62
2.11
9.0
8.1
e9/l
0.0
0.0
0.24
72
546
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
21
3.45
1.99
2.0
5.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
128
1147
2.04
1.98
34.7
15.1
mmol/l
139.2
139.6
1.10
128
1115
(3044941) Cell count panel - Synovial fluid
5
11
4.67
1.95
1.8
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
36
235
1.71
1.93
3.9
3.4
umol/l
22449.2
3626.3
0.39
29
206
(3023103) Potassium [Moles/volume] in Serum or Plasma
128
1150
2.02
1.91
34.7
15.1
mmol/l
4.0
3.9
1.34
128
1117
(42870588) Differential panel, method unspecified - Blood
57
420
1.59
1.91
9.7
9.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
22
3.29
1.90
16.3
19.0
%
75.7
68.6
—
7
22
(3013115) Eosinophils [#/volume] in Blood
81
649
1.57
1.88
9.6
9.0
e9/l
0.2
0.2
0.04
75
574
(3008037) Lactate [Moles/volume] in Venous blood
6
17
3.63
1.86
8.3
2.6
mmol/l
1.8
1.2
—
6
17
(3035285) Chloride [Moles/volume] in Venous blood
5
12
4.27
1.84
5.2
2.6
mmol/l
101.4
108.0
—
5
12
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
12
4.27
1.84
5.2
2.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
23
3.14
1.82
2.7
4.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
18
3.43
1.76
2.0
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
30
2.76
1.75
5.0
3.7
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
24
3.01
1.74
8.0
13.0
—
5222.0
—
0
5
(3005322) IgE [Units/volume] in Serum or Plasma
18
98
1.96
1.71
1.2
1.4
u/ml
157.9
161.5
0.01
18
90
(3021901) Oxygen saturation in Capillary blood
7
25
2.89
1.67
9.4
2.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
42
296
1.59
1.67
4.4
4.2
ph
7.4
7.4
—
7
54
(3038515) Glucose [Moles/volume] in Venous blood
5
15
3.41
1.53
7.6
2.7
mmol/l
8.0
7.1
—
5
15
(3000494) Fungus identified in Specimen by Culture
21
126
1.78
1.50
1.8
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
33
225
1.61
1.49
3.8
3.0
mosm/kgh2o
613.1
553.0
0.55
28
195
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
28
2.57
1.47
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
28
2.57
1.47
1.3
1.3
—
—
—
0
0
(44790049)
5
16
3.20
1.45
2.8
2.1
—
—
—
0
0
(44790048)
5
16
3.20
1.45
2.8
2.1
—
—
—
0
0
(44790047)
5
16
3.20
1.45
2.8
2.1
—
—
—
0
0
(44806118)
5
16
3.20
1.45
2.8
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
16
3.20
1.45
1.8
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
18
105
1.82
1.41
9.3
3.2
g/l
8.9
9.5
0.24
18
97
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
17
3.01
1.37
1.6
4.8
—
528.6
—
0
5
(3020393) Adenovirus Ag [Presence] in Stool
5
17
3.01
1.37
1.2
1.8
—
—
—
0
0
(3013512) EKG study
34
239
1.55
1.35
6.0
3.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
86
729
1.45
1.34
10.9
11.7
e9/l
4.3
3.9
1.05
75
633
(3004588) Protein electrophoresis panel - Serum or Plasma
10
48
2.16
1.31
1.5
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
17
100
1.79
1.30
26.4
9.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
37
2.23
1.23
1.4
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
19
2.69
1.22
2.0
1.9
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
19
2.69
1.22
10.0
3.5
mu/l
18.7
14.4
—
5
19
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
111
0.43
1.19
1.0
1.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
0
33
0.00
1.18
0.0
4.3
—
3.3
—
0
23
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
0
33
0.00
1.18
0.0
4.4
—
557.2
—
0
24
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
30
2.40
1.14
1.4
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
50
396
1.40
1.09
3.6
3.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
22
2.32
1.04
12.8
3.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
13
76
1.78
1.03
2.0
2.7
ml/min/173m2
87.0
79.4
—
5
36
(3002582) Erythrocytes [#/volume] in Urine
46
363
1.39
1.01
3.5
3.4
e6/l
9.8
46.9
1.40
38
283
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
61
1.87
1.01
1.5
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
89
992
0.73
1.00
3.3
3.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
143
0.53
1.00
1.1
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
116
0.50
0.99
1.0
1.0
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
28
0.00
0.99
0.0
2.8
—
0.1
—
0
21
(3030467) Casts [#/volume] in Urine by Automated count
42
331
1.38
0.93
3.3
3.1
e6/l
1.1
0.2
1.00
31
253
(3020682) Albumin/Creatinine [Ratio] in Urine
31
233
1.42
0.89
4.8
4.0
mg/mmol
20.7
9.9
0.23
23
142
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
269
0.66
0.89
2.8
2.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
13
199
0.62
0.86
1.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
31
1.98
0.85
2.5
2.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
31
1.98
0.85
2.5
2.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
47
1.74
0.82
1.3
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
39
310
1.35
0.81
4.1
2.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
96
0.50
0.81
4.0
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
33
1.85
0.80
2.2
2.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
15
99
1.58
0.79
26.4
8.7
kpa
9.0
9.4
0.42
15
94
(3044290) Cell count panel - Cerebral spinal fluid
0
27
0.00
0.78
0.0
4.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
25
2.03
0.73
1.6
4.3
%
57.2
57.9
—
5
25
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
25
2.03
0.73
1.6
4.3
e9/l
3.3
4.2
—
5
25
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
26
1.96
0.71
1.8
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
246
0.69
0.71
2.7
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
91
0.53
0.69
3.6
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
40
327
1.31
0.69
3.2
3.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
5
27
1.88
0.69
3.6
4.3
kpa
8.6
9.1
—
5
27
(3013290) Carbon dioxide [Partial pressure] in Blood
5
27
1.88
0.69
3.6
4.3
kpa
5.0
4.8
—
5
27
(3035637) Corticotropin [Mass/volume] in Plasma
5
27
1.88
0.69
2.0
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
95
0.51
0.69
3.6
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
43
1.66
0.68
2.0
2.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
50
423
1.28
0.67
4.1
4.0
e6/l
11.0
36.2
2.48
40
301
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
28
1.81
0.67
1.2
2.9
umol/l
12.9
6.3
—
5
20
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
29
1.75
0.64
1.2
1.3
—
—
—
0
0
(4010399)
10
63
1.63
0.63
1.5
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
20
262
0.73
0.62
3.2
3.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
20
0.00
0.61
0.0
6.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13
89
1.51
0.60
2.8
3.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
40
334
1.27
0.59
11.9
10.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
23
0.00
0.59
0.0
1.1
—
3.5
—
0
13
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
14
193
0.70
0.58
1.6
1.3
u/ml
1.0
6.4
—
6
79
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
11
74
1.53
0.55
1.3
1.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
99
0.59
0.54
1.5
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
39
1.56
0.53
11.0
2.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
31
254
1.28
0.53
3.0
2.9
e6/l
7.6
5.2
0.37
26
227
(3029937) Albumin [Presence] in Urine by Test strip
25
309
0.77
0.53
3.6
3.7
estimate
0.0
0.0
—
9
116
(3037467) Urinalysis macro (dipstick) panel - Urine
84
770
1.22
0.52
6.1
4.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
103
965
1.24
0.50
21.5
11.0
ml/min/173m2
88.0
90.2
0.31
79
749
(3012516) Albumin [Mass/volume] in Urine
27
219
1.29
0.50
4.3
3.3
mg/l
40.0
80.9
0.40
22
139
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
77
1.46
0.47
2.1
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
49
1.45
0.46
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
34
287
1.24
0.46
3.2
4.8
—
—
—
0
0
(3000492) Spirometry study
15
113
1.37
0.45
1.5
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
16
205
0.75
0.44
1.1
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
92
0.64
0.44
1.2
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
31
1.63
0.43
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
237
0.77
0.43
1.5
1.8
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.5
—
59.2
—
0
15
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
115.4
—
0
15
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
34
1.49
0.41
3.0
2.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
41
358
1.20
0.40
2.5
1.7
pmol/l
101.6
96.7
0.32
30
173
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
33
382
0.82
0.40
2.2
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
35
1.44
0.39
3.0
2.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
35
402
0.83
0.39
2.7
2.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
107
1.34
0.39
10.7
6.6
—
—
—
0
0
(3019225) pH of Specimen
9
69
1.32
0.38
6.2
6.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
133
1359
0.72
0.37
39.3
19.1
g/l
133.2
135.8
1.06
133
1343
(3010813) Leukocytes [#/volume] in Blood
133
1359
0.72
0.37
38.7
19.0
e9/l
6.6
6.7
0.18
133
1319
(3003694) ABO and Rh group [Type] in Blood
42
371
1.19
0.37
1.4
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
63
577
1.16
0.35
14.8
11.3
e9/l
0.0
0.0
0.50
50
459
(3026361) Erythrocytes [#/volume] in Blood
133
1358
0.73
0.35
38.6
19.0
e12/l
4.5
4.6
0.54
133
1320
(3035941) MCH [Entitic mass]
133
1358
0.73
0.35
38.5
18.9
pg
29.9
29.8
0.18
133
1343
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
23
192
1.24
0.35
3.3
2.6
e6/l
0.7
0.7
0.02
15
113
(3020891) Body temperature
6
45
1.35
0.34
5.3
5.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
133
1357
0.74
0.33
38.6
18.9
fl
90.0
89.1
1.25
133
1342
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
47
1.29
0.32
3.0
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
39
435
0.86
0.31
4.6
3.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
31
348
0.86
0.26
1.9
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
73
1.25
0.26
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
81
0.73
0.25
1.3
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
8.8
—
0
10
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
12
0.00
0.21
0.0
1.0
—
167.4
—
0
12
(3036071) Salmonella sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
4.8
—
3.1
—
0
13
(3016018) Differential panel - Cerebral spinal fluid
0
13
0.00
0.21
0.0
5.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
6
48
1.26
0.20
2.8
1.9
u/ml
181.0
142.9
—
6
27
(3007164) IgA [Mass/volume] in Serum or Plasma
39
358
1.12
0.20
1.6
1.6
g/l
2.2
2.1
0.21
23
193
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
17.5
—
1452.6
—
0
14
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
11.1
—
792.2
—
0
14
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
49
1.23
0.20
3.0
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
104
1007
1.12
0.20
4.5
3.7
mmol/l
5.9
5.7
0.46
98
927
(3023511) Choriogonadotropin [Units/volume] in Urine
6
52
1.16
0.19
2.2
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
124
1215
1.15
0.18
28.0
12.9
mg/l
20.1
21.0
0.13
112
921
(3009261) Glucose [Presence] in Urine by Test strip
53
561
0.91
0.17
4.1
3.5
estimate
0.0
0.0
—
9
110
(40761511) CBC panel - Blood by Automated count
127
1247
1.16
0.17
27.0
10.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
119
0.83
0.16
2.1
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
10
84
1.20
0.14
3.2
2.2
nmol/l
10.3
13.1
—
10
79
(40761536) Microorganisms panel - Urine sediment
8
97
0.81
0.14
4.0
3.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
99
0.80
0.14
1.3
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
116
1181
0.91
0.13
37.6
14.7
%
38.6
40.3
1.28
93
969
(3021601) Nitrite [Presence] in Urine by Test strip
53
555
0.93
0.12
6.3
4.7
estimate
0.0
0.0
—
10
116
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
20
182
1.11
0.12
3.7
2.8
e6/l
4.9
2.9
0.18
13
103
(3035350) Ketones [Presence] in Urine by Test strip
54
562
0.94
0.10
4.0
3.4
estimate
0.0
0.0
—
10
114
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
48
1.04
0.09
3.0
2.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
114
1122
1.08
0.09
36.1
17.0
g/l
331.6
334.1
1.88
114
1117
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
36
378
0.94
0.09
1.7
1.6
u/ml
0.8
1.9
—
8
83
(3001019) Free T4 and TSH panel - Serum or Plasma
6
56
1.07
0.09
2.3
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
195
1.09
0.08
1.9
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
5
64
0.77
0.08
1.0
1.8
mu/l
195.2
322.4
—
5
58
(3015736) pH of Urine
46
443
1.06
0.07
4.1
3.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
8
77
1.04
0.07
4.9
4.2
mmol/l
1.2
1.2
—
8
66
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
96
944
1.05
0.07
6.3
4.8
mmol/mol
39.2
38.5
0.33
91
888
(3002256) Pathology report gross observation
12
131
0.91
0.06
1.4
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
149
0.93
0.03
2.1
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
18
171
1.06
0.03
5.9
4.2
%
18.4
22.4
0.51
11
71
(3041096) Erythrocytes [Presence] in Urine by Automated
32
323
0.99
0.00
4.5
3.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
265
0.98
0.00
1.7
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
135
1.04
0.00
1.5
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
15
145
1.04
0.00
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
115
1.05
0.00
1.5
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
2.0
—
0
6
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
6.3
—
0
6
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
84
0.95
0.00
2.4
1.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.3
—
0
6
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
9.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
17.7
—
8.7
—
0
6
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
35.6
—
0.4
—
0
5
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
49
1.02
0.00
1.6
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
9.7
—
0
5
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.3
—
6.0
—
0
8
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
0.0
—
0
7
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
8
80
1.00
0.00
3.0
2.5
iu/l
13.1
19.7
—
8
59
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
8.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
57
0.87
0.00
1.6
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
77
0.90
0.00
2.9
3.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
49
1.02
0.00
1.6
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
49
1.02
0.00
1.6
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
120
1.00
0.00
1.4
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
7.0
—
250.5
—
0
7
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
7
75
0.93
0.00
2.7
4.6
ug/l
2.2
10.8
—
7
53
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
49
1.02
0.00
1.6
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
45.3
—
0
5
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4035726)
8
89
0.89
0.00
3.0
1.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
77
0.90
0.00
1.0
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
8
0.00
0.00
0.0
6.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_AVSD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_AVSD | 4.493 [3.29, 6.14] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.172 |
During the follow-up period (1.1.1998 — 31.12.2019), 95 out of 688 females with Q17_AVSD died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_AVSD | 4.775 [3.37, 6.76] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 82 out of 494 males with Q17_AVSD died.
Mortality risk
Mortality risk for people of age
years, who have Q17_AVSD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.368% | 0.978% |
| 5 | 2.179% | 6.07% |
| 10 | 6.341% | 13.382% |
| 15 | 11.155% | 23.091% |
| 20 | 19.056% | 36.039% |
Relationships between endpoints
↥Index endpoint: Q17_AVSD – Atrioventricular septal defect
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data